SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-020841
Filing Date
2020-11-09
Accepted
2020-11-09 17:03:31
Documents
71
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 915734
2 ex31-1.htm EX-31.1 21943
3 ex31-2.htm EX-31.2 21778
4 ex32-1.htm EX-32.1 6900
5 ex32-2.htm EX-32.2 6877
  Complete submission text file 0001493152-20-020841.txt   5296343

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE crbp-20200930.xsd EX-101.SCH 45517
7 XBRL CALCULATION FILE crbp-20200930_cal.xml EX-101.CAL 52374
8 XBRL DEFINITION FILE crbp-20200930_def.xml EX-101.DEF 215290
9 XBRL LABEL FILE crbp-20200930_lab.xml EX-101.LAB 383987
10 XBRL PRESENTATION FILE crbp-20200930_pre.xml EX-101.PRE 323591
11 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 712044
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37348 | Film No.: 201298614
SIC: 2834 Pharmaceutical Preparations